Hydrochloric Acid

Hydrochloric Acid

SCHEMBL11029439

C=CCc1cccc(C)c1O[Ti+2]C1=C(C)C(C)=C(C)C1(C)C.[Cl-].[Cl-]

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33
GABRA1 P14867 1/20 0.31
GABRB2 P47870 1/20 0.31
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL392238 0.83
Hydrochloric Acid SCHEMBL11029441 0.73 ADRA2A (0.33) ADRA2AADRA2BADRA2CGABRA1GABRB2
SCHEMBL10790494 0.70 GABRA1 (0.44) ADRA2AADRA2BADRA2CGABRA1GABRB2
Hydrochloric Acid SCHEMBL3615425 0.70 MEN1 (0.33)
Hydrochloric Acid SCHEMBL394796 0.70 TSHR (0.31) GABRA1GABRB2
SCHEMBL28307193 0.69 GABRA1 (0.43) ADRA2AADRA2BADRA2CGABRA1GABRB2
Hydrochloric Acid SCHEMBL27436289 0.68 ADRA2A (0.41) ADRA2AADRA2BADRA2CGABRA1GABRB2
SCHEMBL5586090 0.67 GABRA1 (0.41) ADRA2AADRA2BADRA2CGABRA1GABRB2
SCHEMBL8997142 0.66 ADRA2A (0.41) ADRA2AADRA2BADRA2CGABRA1GABRB2
SCHEMBL5547437 0.66 GABRA1 (0.40) ADRA2AADRA2BADRA2CGABRA1GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9062134-B2 Half-metallocene compounds and catalyst compositions CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2015-06-23 US disclosed
US-20140243491-A1 Half-Metallocene Compounds and Catalyst Compositions CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2014-08-28 US disclosed
US-8759246-B2 Half-metallocene compounds and catalyst compositions CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2014-06-24 US disclosed
US-20130085060-A1 Half-Metallocene Compounds and Catalyst Compositions CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2013-04-04 US disclosed
US-8309748-B2 Half-metallocene compounds and catalyst compositions CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2012-11-13 US disclosed
US-20120190803-A1 HALF-METALLOCENE COMPOUNDS AND CATALYST COMPOSITIONS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2012-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190803-A1 HALF-METALLOCENE COMPOUNDS AND CATALYST COMPOSITIONS POLM, AP2M1, GSTM2 ADRA2A 4149/4885ADRA2B 4519/4885ADRA2C 4354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.